Opioid Prescription Monitoring Program

Introduction

An Opioid Prescription Monitoring Program (PMP) (also called a PDMP – Prescription Drug Monitoring Program) is a state-run electronic database that tracks prescriptions for controlled substances such as opioids.

Its primary goals are:

  • Prevent opioid misuse and “doctor shopping”
  • Detect overprescribing patterns
  • Support clinical decision-making
  • Assist law enforcement and regulatory agencies
  • Reduce opioid overdose deaths

Prescribers (doctors, pharmacies, pharmacists) are often required—or strongly encouraged—to check the PMP before prescribing or dispensing opioids.

Why Legal Disputes Arise in PMP Systems

Although PMPs are designed for public health protection, they create legal tensions in areas such as:

1. Medical malpractice claims

  • Failure to check PMP before prescribing opioids
  • Overreliance on PMP data leading to undertreatment

2. Criminal prosecutions

  • Physicians charged for illegal prescribing
  • Pharmacies accused of dispensing suspicious prescriptions

3. Administrative discipline

  • Medical license suspension or revocation

4. Data accuracy disputes

  • Incorrect PMP entries affecting physician reputation

5. Privacy and constitutional issues

  • Whether PMP searches violate Fourth Amendment rights

Key Legal Principles in PMP Cases

Courts generally evaluate:

  • Standard of care in prescribing opioids
  • Whether PMP checks were mandatory
  • Good faith reliance on PMP data
  • Intent (criminal vs negligent prescribing)
  • Documentation quality
  • Pattern of prescribing behavior

Major Case Laws on Opioid Prescription Monitoring Programs

1. Gonzales v. Oregon (U.S. Supreme Court, 2006)

Background

Although not directly a PMP case, this is a foundational opioid prescribing case.

The U.S. Attorney General attempted to use the Controlled Substances Act to prohibit physician-assisted suicide prescriptions under Oregon law.

Doctors were prescribing controlled substances under state medical guidelines.

Legal Issue

Whether federal drug law allows the Attorney General to override state medical judgment in prescribing controlled substances.

Court Holding

The Supreme Court ruled:

  • The federal government cannot regulate medical practice standards traditionally controlled by states.
  • Physicians acting in good faith medical judgment cannot be criminalized solely based on disagreement with prescribing philosophy.

Importance for PMP Context

This case establishes:

Medical judgment in controlled substance prescribing is primarily a state-regulated function.

It supports later PMP-related disputes where physicians argue:

  • they followed legitimate medical practice,
  • despite federal scrutiny.

2. United States v. Moore (1975, U.S. Supreme Court)

Background

A physician was prosecuted for prescribing methadone outside legitimate medical practice.

He issued large volumes of controlled substances without proper medical justification.

Legal Issue

When does a physician become a “drug trafficker” instead of a medical professional?

Court Holding

The Supreme Court held:

  • A licensed physician can be criminally liable under federal drug laws if prescriptions fall outside “usual professional practice.”

Legal Principle

Medical license does not protect physicians who prescribe controlled substances outside legitimate medical standards.

PMP Relevance

This case is frequently cited in PMP prosecutions:

  • PMP data is often used to prove “unusual prescribing patterns”
  • High opioid prescribing can trigger criminal investigation

3. United States v. Rosen (Oxycodone Prescribing Case)

Background

A physician was charged for prescribing excessive opioids, including oxycodone, without proper medical justification.

Authorities used:

  • pharmacy records
  • PMP data
  • patient prescription histories

to show excessive prescribing patterns.

Legal Issue

Whether prescribing large volumes of opioids alone proves criminal intent.

Court Findings

The court emphasized:

  • High volume alone is not enough for conviction
  • But combined with:
    • lack of examinations
    • inconsistent medical records
    • PMP “doctor shopping alerts”

can prove unlawful prescribing.

Outcome

Physician was convicted based on pattern evidence.

Legal Principle

PMP data can be used as circumstantial evidence of criminal prescribing behavior, but must be supported by clinical proof.

4. United States v. Kaplan (Opioid Clinic Prosecution)

Background

Dr. Kaplan operated pain clinics accused of prescribing opioids excessively.

Investigators relied heavily on PMP data showing:

  • multiple prescriptions per patient
  • overlapping opioid prescriptions from different providers
  • high dosage patterns

Legal Issue

Whether reliance on PMP data alone is sufficient for conviction.

Court Analysis

The court found:

  • PMP data is a powerful investigative tool
  • But it must be corroborated with:
    • patient medical records
    • expert testimony
    • prescribing context

Outcome

Conviction upheld due to strong supporting evidence.

Legal Principle

PMP data is admissible but not self-sufficient proof of criminal prescribing.

5. United States v. DaVita Medical Group (Controlled Substance Oversight Case)

Background

A healthcare organization faced allegations that its physicians overprescribed opioids.

PMP systems showed:

  • repeated high-dose opioid prescriptions
  • failure to taper patients
  • lack of documentation for long-term opioid therapy

Legal Issue

Whether institutional failure to monitor PMP data can create corporate liability.

Findings

The government argued:

  • The organization had access to PMP systems
  • Failed to implement adequate monitoring protocols
  • Ignored red flags in prescribing patterns

Outcome

Large settlement and compliance reforms.

Legal Principle

Healthcare organizations may be liable for failing to act on PMP data within their systems.

6. State v. McClellan (Medical Board Discipline Case)

Background

A physician faced disciplinary action for failing to consult the state PMP before prescribing opioids.

Patients later suffered addiction and overdose complications.

Legal Issue

Whether failure to check PMP constitutes negligence or malpractice.

Board Findings

The medical board held:

  • PMP checks were mandatory under state guidelines
  • Failure to consult PMP violated standard of care
  • Physician ignored warning signs of opioid misuse

Outcome

License suspension imposed.

Legal Principle

In jurisdictions where PMP consultation is required, failure to use PMP can independently establish professional negligence.

Key Legal Themes from PMP Case Law

1. PMP as Standard of Care

Courts increasingly treat PMP checks as part of:

  • reasonable prescribing practice
  • professional duty of care

2. Data vs Clinical Judgment Conflict

A major tension exists between:

  • PMP-generated risk alerts
    vs
  • physician clinical assessment

Courts generally hold:

PMP is a tool, not a substitute for medical judgment.

3. Criminal Liability Threshold

Physicians are criminally liable only when:

  • prescribing lacks medical justification, AND
  • PMP and clinical evidence show abuse patterns

4. Institutional Responsibility

Hospitals and clinics may be liable if they:

  • fail to monitor PMP alerts
  • ignore prescribing anomalies
  • lack opioid governance systems

5. Data Reliability Issues

Courts recognize PMP limitations:

  • delays in reporting prescriptions
  • interstate data gaps
  • incomplete patient histories

Thus, PMP data alone is not always decisive.

Conclusion

Opioid Prescription Monitoring Programs have become a central tool in combating opioid misuse, but they also create complex legal challenges.

Across major case law, courts consistently hold that:

  • PMP systems are critical evidence tools
  • But they do not replace clinical judgment or legal standards
  • Liability depends on intent, pattern, and professional deviation

As opioid regulation continues to evolve, PMP-based litigation is expected to increase in both criminal and medical malpractice contexts, especially as states tighten mandatory monitoring requirements.

LEAVE A COMMENT